Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Biotechnology Portfolio

+ Add to Watchlist

FBIOX:US

259.78 USD 4.67 1.77%

As of 09:29:30 ET on 04/17/2015.

Snapshot for Fidelity Select Biotechnology Portfolio (FBIOX)

Year To Date: +20.25% 3-Month: +14.38% 3-Year: +47.73% 52-Week Range: 152.33 - 266.53
1-Month: -0.31% 1-Year: +67.76% 5-Year: +33.45% Beta vs MXWO: 1.03

Mutual Fund Chart for FBIOX

No chart data available.
  • FBIOX:US 259.78
  • 1M
  • 1Y
Interactive FBIOX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBIOX

Fidelity Select Biotechnology Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-16-1985 Telephone: 1-800-544-6666
Managers: RAJIV KAUL
Web Site: www.fidelity.com

Fundamentals for FBIOX

NAV (on 2015-04-17) 259.78
Assets (M) (on 2015-03-31) 14,208.72
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBIOX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2015-04-10) 6.28
Dividend Yield (ttm) 11.59

Fees & Expenses for FBIOX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.75

Top Fund Holdings for FBIOX

Filing Date: 02/28/2015
Name Position Value % of Total
Gilead Sciences Inc 10,119,193 1,047,640,051 7.884%
Biogen Inc 2,284,539 935,724,329 7.042%
Celgene Corp 6,670,752 810,696,491 6.101%
Vertex Pharmaceuticals Inc 4,835,194 577,467,219 4.346%
Alexion Pharmaceuticals Inc 2,688,470 484,919,334 3.649%
Regeneron Pharmaceuticals Inc 1,132,070 468,495,849 3.526%
BioMarin Pharmaceutical Inc 3,027,106 324,112,239 2.439%
Medivation Inc 2,549,127 299,598,896 2.255%
Receptos Inc 2,292,011 290,260,273 2.184%
Pharmacyclics Inc 1,300,713 280,862,958 2.114%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil